Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
23:13
The Hungarian government will offer owners of eligible diesel cars 5,000 forints per month until the end of the year
22:57
Peter Magyar announces changes to Hungary’s adoption law for same-sex couples
22:38
Bucharest entered the Book of Records with “The Table That Unites.” Ciucu: “There was a big dining room today, in Constitution Square”
22:14
Anthropic’s CEO calls for slowing AI development, warning that intelligent agents could take control of the internet in the coming months
21:26
Sergey Lavrov responds to Volodymyr Zelensky: “Let him come to Moscow” for a meeting with Vladimir Putin
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
